Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARGONAUT: Development and Analysis of a Blood and Stool Sample Bank for Cancer Patients, Enabling the Systematic Study of the Effect of Gut Microbiomes on Response to Treatment

NCT04638751 is registered in ClinicalTrials.gov with Persephone Biosciences as lead sponsor.

NCT NCT04638751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04638751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARGONAUT: Development and Analysis of a Blood and Stool Sample Bank for Cancer Patients, Enabling the Systematic Study of the Effect of Gut Microbiomes on Response to Treatment
Lead sponsor
Persephone Biosciences
Phase
Observational
Overall status
Suspended
Start date
July 1, 2022
Completion date
December 31, 2028
Enrollment
5,000 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, non-small cell lung cancer, pancreas cancer, triple negative breast cancer